Cell Assay Innovations (CAI) is a company that specializes in cell-based assay technology development. It focuses on detecting post-translational modifications such as phosphorylation, epigenetics (methylation, acetylation), and others, in a physiologically relevant cellular setting. In addition, the company provides cost-effective services related to drug discovery, cell culture, and in vitro biology.